by Claudia Li | Jul 24, 2023 | Press Releases
Press release DiaCarta and HMC/HML Team up for Customizing Lab Development Test Validations and Compliances in the US Market FollowFollow DiaCarta, Ltd. (“DiaCarta”), a novel molecular diagnostic test developer for cancer and infectious diseases, today announced that...
by Claudia Li | Jul 6, 2023 | Press Releases
Press release DiaCarta Announces the Termination of Business Combination Agreement with HH&L Acquisition Co. FollowFollow DiaCarta, Ltd. (“DiaCarta”), a precision molecular diagnostics company, today announced the termination of its Business Combination Agreement...
Recent Comments